NOVO HOLDINGS A/S - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, NOVO HOLDINGS A/S held in its portfolio 24 assets valued at $1,287,677,054 (i.e. $1.29B).

The most valuable assets in the portfolio included: BROOKFIELD CORP ($160.44M), EDGEWISE THERAPEUTICS INC ($132.76M), and ASML HOLDING N V ($121.91M).

The chart below shows the top 10 valuable assets, and the table below shows the top 24 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.
Data Source: SEC.
Top Valuable Stocks in NOVO HOLDINGS A/S Portfolio
BROOKFIELD CORP
EDGEWISE THERAPEUTICS INC
ASML HOLDING N V
MIRUM PHARMACEUTICALS INC
SALESFORCE INC
CRINETICS PHARMACEUTICALS IN
VIRIDIAN THERAPEUTICS INC
MAPLIGHT THERAPEUTICS INC
ZENAS BIOPHARMA INC
PHARVARIS N V
NOVO HOLDINGS A/S - Stock Holdings in 13F Filings (SEC)
Items per page:
0 of 0
Name of Issuer No. of Shares Value ($) Class
BROOKFIELD CORP 3496245 160442683 CL A LTD VT SH
EDGEWISE THERAPEUTICS INC 5350000 132760250 COM
ASML HOLDING N V 113946 121906268 N Y REGISTRY SHS
MIRUM PHARMACEUTICALS INC 1264028 99845572 COM
SALESFORCE INC 330187 87469838 COM
CRINETICS PHARMACEUTICALS IN 1625000 75643750 COM
VIRIDIAN THERAPEUTICS INC 2380000 74065600 COM
MAPLIGHT THERAPEUTICS INC 3686622 64755515 COM
ZENAS BIOPHARMA INC 1450000 52649500 COM
PHARVARIS N V 1750000 48562500 COM
APOGEE THERAPEUTICS INC 570000 43023600 COM
VAXCYTE INC 916160 42271622 COM
BIOMARIN PHARMACEUTICAL INC 660000 39223800 COM
ARRIVENT BIOPHARMA INC 1942142 39075897 COM
ALIBABA GROUP HLDG LTD 257327 37718992 SPONSORED ADS
INSMED INC 200000 34808000 COM PAR $.01
CELLDEX THERAPEUTICS INC NEW 1200000 32592000 COM NEW
4D MOLECULAR THERAPEUTICS IN 3650737 27380528 COM
BRIDGEBIO ONCOLOGY THERAPEUT 1961317 24555689 COM NEW
ENLIVEN THERAPEUTICS INC 1480000 22792000 COM
VALNEVA SE 2305000 20330100 SPONSORED ADS
LANZATECH GLOBAL INC 158148 2176116 COM NEW
MARQETA INC 441558 2097401 CLASS A COM
IO BIOTECH INC 2512453 1529833 COM